PETFLOGIN 5 MG/TAB ΔΙΣΚΙΟ
PETFLOGIN 5 MG/TAB ΔΙΣΚΙΟ
Authorised
- Prednisolone
Product identification
Medicine name:
PETFLOGIN 5 MG/TAB ΔΙΣΚΙΟ
Active substance:
- Prednisolone
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Prednisolone5.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Not applicableno withdrawal period
-
-
Dog
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 116647/04-11-2022/K-0253801
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 7/06/2023
Updated on: 9/06/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 7/06/2023
Updated on: 9/06/2023
How useful was this page?:
